Combined Iron Chelator and Antioxidant Exerted Greater Efficacy on Cardioprotection Than Monotherapy in Iron-Overloaded Rats.
Iron chelators are used to treat iron overload cardiomyopathy patients. However, a direct comparison of the benefits of three common iron chelators (deferoxamine (DFO), deferiprone (DFP) and deferasirox (DFX)) or an antioxidant (N-acetyl cysteine (NAC)) with a combined DFP and NAC treatments on left...
Glavni autori: | , , , , , , , |
---|---|
Format: | Članak |
Jezik: | English |
Izdano: |
Public Library of Science (PLoS)
2016-01-01
|
Serija: | PLoS ONE |
Online pristup: | http://europepmc.org/articles/PMC4948821?pdf=render |